-
GENERAL PSYCHIATRYPlacebo Response in Depression: A Perspective for Clinical Practice
By Arif Khan, Shirin Khan
-
EVIDENCE-BASED MEDICINE
Psychometric Evaluation of a Patient-Rated Troubling Symptom Scale for Generalized Anxiety Disorder Clinical Trials
By Gahan J. Pandina, Dennis A. Revicki, Leah Kleinman, Ibrahim Turkoz, Jasmanda Wu, Ramy Mahmoud, Georges M. Gharabawi
-
EVIDENCE-BASED MEDICINE
Developing and Testing Adaptive Treatment Strategies Using Substance-Induced Psychosis as an Example
By Ree Dawson, Alan I. Green, Robert E. Drake, Thomas H. McGlashan, Bella Schanzer, Philip W. Lavori
-
EVIDENCE-BASED MEDICINE
A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders
By Patricia Berney, Demian Halperin, Rodrigo Tango, Isabelle Daeniker-Dayer, Pierre Schulz
-
ORIGINAL RESEARCHThe Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Hospitalized Patients with Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Study
By Jean-Pierre Lindenmayer, David Brown, Sherry Liu,
-
ORIGINAL RESEARCHCocaine is a Major Risk Factor for Antipsychotic Induced Akathisia, Parkinsonism and Dyskinesia
By Arija Maat, Annemarie Fouwels, Lieuwe de Haan
-
Continuous Positive Airways Pressure Treatment in a Patient with Sleep Apnea—Hypopnea Syndrome and Coexisting Bipolar Disorder
By Georgia Trakada, MD, Pashalis Steiropoulos, MD, and Demosthenes Bouros, MD, FCCP
-
EVIDENCE-BASED MEDICINE
Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy
By Michael E. Thase, MD
-
ORIGINAL RESEARCHAddressing Methodological Issues in Studying Antidepressant Onset Efficacy Using Prespecified Sensitivity Analyses
By Ilya Lipkovich, PhD, Craig H. Mallinckrodt, PhD, Apurva Prakash, BA, and Andrew A. Nierenberg, MD
-
Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice
By Alisa B. Busch, MD, MS, Richard G. Frank, PhD, and Gary Sachs, MD
-
ORIGINAL RESEARCHCriteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
By Prakash S. Masand, MD, James Eudicone, MS, Andrei Pikalov, MD, PhD, Robert D. McQuade, PhD, Ronald N. Marcus, MD, Estelle Vester-Blokland, MD and Berit X. Carlson, PhD
-
Letter to the Editor
AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER
-
GLUCOSE TESTING IN PATIENTS RECEIVING ANTIPSYCHOTIC PHARMACOTHERAPY: AUTHOR REPLY -
LETTER TO THE EDITOR
GLUCOSE TESTING IN PATIENTS RECEIVING ANTIPSYCHOTIC
-
ORIGINAL RESEARCHClinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
By Mark A. Demitrack, Michael E. Thase
-
COMPLICATED CASE HISTORIES
Hypomania Induced by Escitalopram: 2 Case Reports
By Ravi C. Sharma
-
EVIDENCE-BASED MEDICINE
Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?
Alan G. Mallinger, Ellen Frank, Michael E. Thase, Michelle M. Barwell, Nancy DiazGranados, David A. Luck
-
DRUG INTERACTIONS
Desvenlafaxine and Venlafaxine Exert Minimal In Vitro Inhibition of Human Cytochrome P450 and P-Glycoprotein Activities
By Aram Oganesian, Adam D. Shilling, Ruth Young-Sciame, Judy Tran, Adiba Watanyar, Farooq Azam, John Kao, Louis Leung
-
ORIGINAL RESEARCHStatistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action
By Andrew C. Leon
-
COMPLICATED CASE HISTORIES
Efficacy of High-Dose Aripiprazole for Treatment-Resistant Schizoaffective Disorder: A Case Report
By Omer Saatcioglu, Sevda Gumus, Kirkor Kamberyan, Medaim Yanik
-
COMPLICATED CASE HISTORIES
Complete Resolution of Clozapine-Induced Sialorrhea with Low Dose Trihexyphenidyl
By Samir Kumar Praharaj, Sujit Sarkhel, Roshan Vitthalrao Khanande, Vinod Kumar Sinha
-
COMPLICATED CASE HISTORIES
Antidepressant Induced Apathy Responsive to Dose Reduction
By Sreekant Kodela, Pavan Dontineni Venkata
-
Lamotrigine Adjunctive Therapy to Lithium and Divalproex in Depressed Patients with Rapid Cycling Bipolar Disorder and a Recent Substance Use Disorder:
A 12-week, Double-Blind, Placebo-Controlled Pilot Study
Zuowei Wang, Keming Gao, David E. Kemp, Philip K. Chan, Mary Beth Serrano, Carla Conroy, Yiru Fang, Stephen J. Ganocy, Robert L. Findling, Joseph R. Calabrese
-
NEGATIVE AND FAILED CLINICAL TRIAL RESULTS
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
By Andrew J. Cutler, Tram Tran-Johnson, Amir Kalali, Mikael Åström, Martin Brecher, Didier Meulien
-
ORIGINAL RESEARCHMetabolic Syndrome with Different Antipsychotics: A Multicentre Cross-Sectional Study
By Cem Cerit, Meltem Vural, S ̧ükriye Bos ̧gelmez, Eylem Özten, Ahmet Tamer Aker, Mustafa Yıldız
-
ORIGINAL RESEARCHDuloxetine in Military Posttraumatic Stress Disorder
By Gerardo Villarreal, José M. Cañive, Lawrence A. Calais, Gregory Toney, Ashley K. Smith
-
ORIGINAL RESEARCHWhy Do Persons with Bipolar Disorder Stop Their Medication?
By Kavi K. Devulapalli, Rosalinda V. Ignacio, Peter Weiden, Kristin A. Cassidy, Tiffany D. Williams, Roknedin Safavi, Frederic C. Blow, Martha
-
COMPLICATED CASE HISTORIES
Risperidone Induced Ventricular Tachycardia
By M. Nadeem Mazhar, David S. Resch
-
ORIGINAL RESEARCHThe Sex Effects Scale: Pilot Validation in a Healthy Population
By Sidney H. Kennedy, Sakina J. Rizvi, Kari Fulton, Janet Ellis, Lena C. Quilty, Lakshmi Ravindran
-
ORIGINAL RESEARCHTreatment of Pathological Gambling with Naltrexone Pharmacotherapy and Brief Intervention: A Pilot Study
By Tuuli Lahti, Jukka T. Halme, Maiju Pankakoski, David Sinclair, Hannu Alho
-
GENERAL PSYCHIATRYOff-Label Second Generation Antipsychotics for Impulse Regulation Disorders: A Review
Albertine Scheltema Beduin, Lieuwe de Haan
